Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Omega Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4 SCHADE CHRISTIAN S (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 36,713 options to buy @ $4.69, valued at $172.2k
07/12/2023 3 SCHADE CHRISTIAN S (Director) has filed a Form 3 on Omega Therapeutics, Inc.
06/09/2023 4 Boehm Rainer J. (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
06/09/2023 4 BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
06/09/2023 4 AFEYAN NOUBAR (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
06/09/2023 4 MENDLEIN JOHN (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
06/09/2023 4 Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
06/09/2023 4 Levy Elliott M. (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
06/09/2023 4 Szela Mary T (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
03/20/2023 4 Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Sold 10,000 shares @ $8, valued at $80k
03/02/2023 4 Moore Yan (Chief Medical Officer) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 55,000 options to buy @ $6.46, valued at $355.3k
03/02/2023 4 McManus Kevin (Chief Human Resources Officer) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 55,000 options to buy @ $6.46, valued at $355.3k
03/02/2023 4 Karande Mahesh (President and CEO) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 170,000 options to buy @ $6.46, valued at $1.1M
03/02/2023 4 Zeng Ling (See Remarks) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 55,000 options to buy @ $6.46, valued at $355.3k
03/02/2023 4 Reed Joshua (CFO) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 55,000 options to buy @ $6.46, valued at $355.3k
03/02/2023 4 McCauley Thomas (Chief Scientific Officer) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 55,000 options to buy @ $6.46, valued at $355.3k
02/27/2023 4 Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Bought 1,993,986 shares @ $5.78, valued at $11.5M
Bought 1,329,324 shares @ $5.78, valued at $7.7M
02/27/2023 3 Flagship Pioneering Fund VII General Partner LLC (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc.
01/11/2023 4 Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Sold 20,000 shares @ $8, valued at $160k
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2022 4 Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Sold 10,000 shares @ $8, valued at $80k
09/01/2022 4 Boehm Rainer J. (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 36,713 options to buy @ $4.47, valued at $164.1k
09/01/2022 3 Boehm Rainer J. (Director) has filed a Form 3 on Omega Therapeutics, Inc.
06/10/2022 4 Levy Elliott M. (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $3.31, valued at $60k
06/10/2022 4 MENDLEIN JOHN (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $3.31, valued at $60k
06/10/2022 4 BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $3.31, valued at $60k
06/10/2022 4 AFEYAN NOUBAR (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $3.31, valued at $60k
06/10/2022 4 Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $3.31, valued at $60k
06/10/2022 4 Szela Mary T (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $3.31, valued at $60k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy